Skip to content
Clinical Trials – home

Spitalul Clinic Judetean De Urgenta Cluj

VerifiedinfoResponsive

Romania Strada Clinicilor 3-5, 400006 Cluj Napoca, Romania

  • 29 trials recruiting
  • Systemic lupus erythematosus · Colitis ulcerative · Sjogren's syndrome
  • Adults and children

About Specializations

Spitalul Clinic Judetean De Urgenta Cluj in Cluj Napoca, Romania specialises in clinical trials of conditions such as Systemic lupus erythematosus, Colitis ulcerative, Sjogren's syndrome, Type 2 diabetes mellitus, and other specialisations. This site conducts important research.

Main research areas of the site

Immunology and Rheumatology Research

At Spitalul Clinic Judetean De Urgenta Cluj, clinical trials in immune system processes and rheumatology focus on Systemic Lupus Erythematosus, a complex autoimmune disease that can cause widespread inflammation and organ involvement. The research is designed to assess whether new treatments can better control symptoms and improve long-term disease management for adults with active disease.

  • Evaluating a new therapy for Systemic Lupus Erythematosus to improve signs and symptoms
  • Assessing safety and overall treatment effectiveness in adults with moderate to severe disease
  • Following patients over time to better understand long-term control of autoimmune activity

These studies reflect a strong interest in advancing care for inflammatory and autoimmune conditions, with an emphasis on safer and more effective options for patients living with SLE.

Metabolic Disease and Diabetes Studies

The site also supports research in nutritional and metabolic diseases, with a focus on type 2 diabetes. These trials aim to improve blood sugar control and support better treatment outcomes for people whose diabetes remains difficult to manage on standard therapy.

  • Testing a new treatment approach for type 2 diabetes in people with inadequate glycaemic control
  • Comparing blood sugar and weight outcomes against established diabetes therapies
  • Exploring ways to strengthen routine diabetes care for patients using background treatment such as metformin

Research in this area combines metabolic health and treatment effectiveness, helping clarify whether newer options can offer meaningful benefits for people with diabetes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Strada Clinicilor 3-5400006 Cluj NapocaRomania
Recruiting now
29 trials
Conditions studied
53
Partner status
Verified

More sites in Cluj NapocaRomania

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

81 clinical trials

Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:RomaniaRomania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:XMAB942
  • Sponsor:Xencor Inc.
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH
Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Elafibranor
  • Sponsor:Ipsen Bioscience Inc.

Coeliac disease

Recruiting
Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
  • Sponsor:Dr. Falk Pharma GmbH
Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Novartis Pharma AG
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.